Kentuckians who live with diabetes are celebrating a big win.
On Monday, Governor Andy Beshear signed House Bill 95 into law. The bi-partisan bill caps the price of insulin for a 30-day supply at $30.
Gov. Beshear called it a "game-changer" for families and individuals who have been forced to pay hundreds of dollars in markups on the life-saving drug, which costs less than $10 to manufacture.
House Bill 95 also requires health care benefit plans to cover needed equipment, supplies, out-patient treatment training, and education, "to help diabetics stay healthy," explained Gov. Beshear.
In early March, 95 state representatives voted the bill through. The state voting history shows, no lawmakers voted against the bill, but five did not vote. In the Kentucky Senate, a similar vote tally with 35 yeas and three who did not vote.
This is not a new issue on the governor's radar. In the press conference, Gov. Beshear referenced the lawsuit he filed as Kentucky's Attorney General.
"In that lawsuit, we offered examples of how these companies allegedly were increasing the price of insulin over a 10-year period," said Gov. Beshear. "For example prices went up 311% for one product, 285% for another. It increased from $325 per package in 2011 to $530 a package in 2017."
That lawsuit was filed in May 2019, against Eli Lilly, Sanofi-Aventis, and Novo Nordisk. It alleged those who were uninsured or on Medicare Part D were hit the hardest by the companies' business practices.
It is unclear if that lawsuit has been settled, dropped, or remains ongoing.